Close

Incyte's (INCY) Jakafi Granted FDA Orphan Drug Designation in Graft Versus Host Disease

Go back to Incyte's (INCY) Jakafi Granted FDA Orphan Drug Designation in Graft Versus Host Disease
Incyte Genomics, Inc. (NASDAQ: INCY) Delayed: 56.97 -0.15 (0.26%)
Previous Close $57.12    52 Week High $118.49 
Open $57.25    52 Week Low $55.00 
Day High $57.09    P/E N/A 
Day Low $56.77    EPS $-0.56 
Volume 1,883,250